Pharma

USFDA inspects Alembic’s pharma facility in Gujarat

HT Team October 18, 2022: The USFDA has inspected India’s Alembic Pharmaceuticals’ Oncology Injectable Formulation Facility at Panelav, Gujarat, according to a BSE.

Read More
Drugs Pharma

Gavi, Moderna sign pact for Covid-19 vaccines

HQ Team October 18, 2022: Gavi, a public-private partnership Vaccine Alliance, has signed a new pact with Moderna to supply Covid-19 vaccines to low-income countries..

Read More
Drugs Medical Pharma

BioNTech founders hopeful of a cancer vaccine within a decade

Scientists are hopeful of an mRNA based vaccine for cancer

Read More
Drugs Pharma

Biocon signs out-licencing pact with Yoshindo

HQ Team October 17, 2022: Biocon Biologics, a subsidiary of India’s Biocon, has inked an out-licencing pact with Japan’s Yoshindo Inc for selling.

Read More
Drugs Pharma

Adderall shortage due to Teva Pharma manufacturing delays

FDA confirms Adderall shortage due to problems in Teva Pharma's supply pipeline

Read More
Drugs Pharma

Merck pays Moderna $250m for joint development of skin cancer vaccine

Moderna’s mRNA vaccine is being studied in combination with Merck’s Keytruda to treat patients with high-risk melanoma

Read More
Drugs Medical Pharma

Neumora Therapeutics raises $112 million in series B to fund neuro disorder research

Neumora Therapeutics raises $650 million to date to revolutionize treatment of brain diseases

Read More
Drugs Pharma

Stalicla signs license deal for Evgens’ SFX-01

Evgen Pharma and Stalicla sign a $165 million licensing deal for neuro development disorder SFX-01 asset

Read More
Drugs Pharma

Merck’s Covid-19 pill fails initial trial; AstraZenaca’s nasal spray too ineffective

Merck's Covid-19 pill no help in reducing hospitalization or death, Astrazenaca's nasal spray too fails trial

Read More
Pharma

Marksans Pharma to acquire Israel’s Tevapharm’s site in Goa

HQ team October 12, 2022: Marksans Pharma, a listed company, is set to acquire a manufacturing site of Tevapharm, an Indian subsidiary of.

Read More
X